本页面由Tiger Trade Technology Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.40
-0.0600-4.11%
成交量:208.29万
成交额:296.08万
市值:4.83亿
市盈率:-2.15
高:1.46
开:1.46
低:1.40
收:1.46
52周最高:4.46
52周最低:1.04
股本:3.45亿
流通股本:2.84亿
量比:0.54
换手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-0.6510
每股收益(LYR):-0.8652
净资产收益率:-42.39%
总资产收益率:-22.08%
市净率:1.11
市盈率(LYR):-1.62

数据加载中...

2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/12

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/11

重要事件披露

Form 8-K - Current report
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]